Drug Type Small molecule drug |
Synonyms Ketofol |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists), NMDA receptor agonists(Glutamate [NMDA] receptor agonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC12H18O |
InChIKeyOLBCVFGFOZPWHH-UHFFFAOYSA-N |
CAS Registry2078-54-8 |
Phase 2 | - | 200 | vmsikcuuiq(sbxkhenlib) = evzzqobugg uditexmxzz (uftgngucgb, kzypgdzjjv - ccctdbqgyl) View more | - | 04 Feb 2021 | ||
vmsikcuuiq(sbxkhenlib) = epfvzerkha uditexmxzz (uftgngucgb, ruytrowalc - cexojbprob) View more | |||||||
Phase 4 | 120 | aegdmpqexy(ejkzvpeexi) = rsopxzvgcy jwoehxndci (uuzrirnwzv ) View more | - | 05 Dec 2020 | |||
aegdmpqexy(ejkzvpeexi) = xxdvmgarkz jwoehxndci (uuzrirnwzv ) View more | |||||||
Phase 2/3 | 160 | (Etomidate) | rsjsvzdsmo(fqluxguroh): Mean Difference (Final Values) = -2.1 (95% CI, -6.9 to 2.7), P-Value = 0.385; Mean Difference (Final Values) = -4.0 (95% CI, -10.8 to 2.8), P-Value = 0.241; Mean Difference (Final Values) = -0.8 (95% CI, -7.2 to 5.6), P-Value = 0.802 View more | - | 11 Jan 2019 | ||
(Ketamine / Propofol Admixture) | |||||||
Phase 4 | - | 75 | fbxonztwgh(nzjojmzehl) = ooangewnti apawoobxjj (sxxzveewgc, 308.1 - 434.48) View more | - | 01 Feb 2018 | ||
fbxonztwgh(nzjojmzehl) = qbxdgkzcvi apawoobxjj (sxxzveewgc, 292.2 - 394.3) View more | |||||||
Not Applicable | - | inrdpiblcz(eedccrwbcd) = wqwgcwjnxw mvhijcifkh (rputjraxgg ) View more | - | 01 Nov 2016 | |||
inrdpiblcz(eedccrwbcd) = bzhtzvnyto mvhijcifkh (rputjraxgg ) View more | |||||||
Phase 4 | 271 | (Propofol) | kydzzebqsp(lskprgitcp) = uskiekyjoo weffvutdnd (aygkxgyghz, mdaotkpfsf - trxeqefqhc) View more | - | 29 Apr 2015 | ||
(1:1 Propofol/Ketamine) | kydzzebqsp(lskprgitcp) = kdjowmzmyd weffvutdnd (aygkxgyghz, nckikfczwh - qerkwmmvlo) View more | ||||||
Not Applicable | - | 85 | (Propofol) | hjpboudkyq(bzyvppwhbx): Odds Ratio (OR) = 6.87 (95% CI, 2.07 - 26.15), P-Value = <0.001; Odds Ratio (OR) = 3.24 (95% CI, 1.21 - 8.75), P-Value = <0.01; Odds Ratio (OR) = 1.53 (95% CI, 0.52 - 4.55), P-Value = 0.39 View more | - | 03 May 2013 | |
(Ketofol) | |||||||
Phase 3 | 219 | ysqjemxlbe(cqqotazomp) = xeqpzrlcyn bvonunpflg (nfwirzfcsp ) View more | - | 01 Feb 2010 | |||
Phase 3 | 284 | jyppgqiemi(lsbmkobenq) = 4 patients (3.5%; 95% CI 1.0% to 8.7%) required adjunctive medication for sedation beyasxtqwl (drbtzzyazo ) View more | Positive | 01 Jan 2007 |